Medicared For All Logo

Mazen Khalil MD in Jonesboro, Arkansas

Home Arkansas Jonesboro

Mazen Khalil MD has Internal Medicine as his primary medical specialty. Their primary office is: 225 E Jackson Ave in Jonesboro, Arkansas.

They're a part of the: Cancer Care Associates Inc medical group which has around 18 members. You can call their office at 870-207-8210 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mazen Khalil MD Office Phone and Directions

Mazen Khalil MD
Cancer Care Associates Inc
225 E Jackson Ave
Jonesboro, Arkansas 72401
870-207-8210

Patient Ratings
Please rate your experience with Mazen Khalil MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 870-207-8210


Enter a starting address:


Healthcare Info for Mazen Khalil MD

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1994
The Primary Medical Specialty for Mazen Khalil MD is listed as: Internal Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 5799798542
NPI #: 1659323608
NPI Created On: 05/17/2006
NPI Last Updated Listed as: 10/24/2008
Primary Taxonomy Code: 207RH0003X
License Number:
40968
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Ambetter
  • QualChoice Life & Health Insurance Company, Inc.
  • USAble Mutual Insurance Company
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: None.

Services and Procedures include:

  1. New patient office or other outpatient visit, typically 60 minutes
  2. New patient office or other outpatient visit, typically 60 minutes
  3. Established patient office or other outpatient visit, typically 15 minutes
  4. Established patient office or other outpatient visit, typically 15 minutes
  5. Established patient office or other outpatient, visit typically 25 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788527993

Being Disputed:: No

Product Related: No

Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788527995

Being Disputed:: No

Product Related: No

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788527997

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788527999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528003

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528001

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528005

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528007

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528009

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788528017

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Internal Medicine Professionals in Jonesboro

1.
Robert Taylor MD

1111 Windover Rd
Jonesboro, AR
Northeast Arkansas Clinic Charitable Foundation, Inc.

2.
Robert Taylor MD

4800 E Johnson Ave
Jonesboro, AR
Northeast Arkansas Clinic Charitable Foundation, Inc.

3.
Robert Taylor MD

4802 E Johnson Ave
Jonesboro, AR
Northeast Arkansas Clinic Charitable Foundation, Inc.

4.
Robert Taylor MD

4808 E Johnson Ave
Jonesboro, AR
Northeast Arkansas Clinic Charitable Foundation, Inc.

5.
Volha Liaukovich

300 Carson St
Jonesboro, AR
St Bernards Hospital Inc.

6.
Volha Liaukovich

1201 Fleming Ave
Jonesboro, AR
St Bernards Hospital Inc.

Providers in Cancer Care Associates Inc

1.Isam Abdel-karim

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Hematology/oncology

2.Hiba Ahmed

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Radiation Oncology

3.Lori Black

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Nurse Practitioner

4.Ashley Denton

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Nurse Practitioner

5.Humdum Durrani

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Hematology

6.Veronica Easton

225 E Washington Ave
Jonesboro Ar 72401-3111
Cancer Care Associates Inc
Internal Medicine

View all 18 members of Cancer Care Associates Inc medical group


Medicared For All
Vote!
Share